Plasma Fractionation Market Analysis 2023-2028: Insights Into Industry Growth, Strategic Planning, Driving Forces, and Future Projections.
In April 2023, CSL (Australia) received Food and Drug Administration (FDA) approval for the 50mL/10gm prefilled syringe for Hizentra (Immune Globulin Subcutaneous [Human] 20% Liquid for patients suffering from PI and CIPD.
View full press release